HDAC抑制剂通过表观遗传调控恢复Foxp3+调节性T细胞改善肺动脉高压
该研究探讨HDAC与调节性T细胞(Tregs)在肺动脉高压(PAH)中的功能联系。在特发性PAH患者及多种啮齿类PH模型中,HDAC表达升高伴随Foxp3+ Tregs减少和PD-1信号增强。HDAC抑制剂伏立诺他(SAHA)可诱导Foxp3+ Treg转化、减轻PH表型并抑制内皮趋化因子释放,且雌性大鼠效应更显著,提示表观遗传治疗PAH的潜力。
要点
- IPAH患者外周血单个核细胞中HDAC表达升高与Foxp3+ Tregs减少及PD-1信号增强相关。
- HDAC抑制剂SAHA可恢复PH大鼠FOXP3转录和Tregs,并减轻PH表型,雌性大鼠效应更明显。
- 选择性清除CD25+ Tregs可中和SAHA的疗效,提示Treg恢复是SAHA作用的关键环节。
核心结论
- HDAC异常与Foxp3+ Treg缺陷相关,揭示了PAH免疫功能障碍的表观遗传机制。
- 通过HDAC抑制剂恢复Foxp3+ Tregs是解决肺血管病理的有前景策略。
研究设计与样本
- 研究纳入特发性PAH患者外周血单个核细胞,并采用野百合碱大鼠、Sugen5416-缺氧大鼠及Treg清除小鼠等PH模型。
- 使用HDAC抑制剂伏立诺他(SAHA)在体内、离体和体外评估免疫调节效应。
主要发现
- IPAH患者外周血单个核细胞中HDAC表达升高,伴随Foxp3+ Tregs减少和PD-1信号增强。
- SAHA差异化修饰一组表观遗传敏感基因,并诱导IPAH T细胞向Foxp3+ Treg转化。
- 啮齿类模型重现了上述表观遗传异常和T细胞功能障碍。
- SAHA减轻PH大鼠表型并恢复FOXP3转录和Tregs,雌性大鼠效应更显著。
- 在Sugen5416-缺氧小鼠中清除CD25+ Tregs可中和SAHA效应;SAHA抑制刺激后内皮细胞因子/趋化因子释放及免疫趋化。
临床怎么用
- HDAC表达和Foxp3+ Treg水平可能作为PAH免疫功能障碍的候选生物标志物。
- HDAC抑制剂(如SAHA)恢复Tregs代表PAH表观遗传治疗的新方向,但需进一步临床验证。
局限性
- 研究主要基于体外实验和啮齿类模型,人体内证据有限。
- SAHA疗效存在性别差异,需在更广泛人群中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Immune dysregulation is a common feature of pulmonary arterial hypertension (PAH). Histone deacetylase (HDAC)-dependent transcriptional reprogramming epigenetically modulates immune homeostasis and is a novel disease-oriented approach in modern times. Objectives: To identify a novel functional link between HDAC and regulatory T cells (Tregs) in PAH, aiming to establish disease-modified biomarkers and therapeutic targets. Methods: Peripheral blood mononuclear cells were isolated from patients with idiopathic PAH (IPAH) and rodent models of pulmonary hypertension (PH): monocrotaline rats, Sugen5416-hypoxia rats, and Treg-depleted mice. HDAC inhibitor vorinostat (suberoylanilide hydroxamic acid, SAHA) was used to examine the immune modulatory effects in vivo, ex vivo, and in vitro. Measurements and Main Results: Increased HDAC expression was associated with reduced Foxp3+ Tregs and increased PD-1 (programmed cell death-1) signaling in peripheral blood mononuclear cells from patients with IPAH. SAHA differentially modified a cluster of epigenetic-sensitive genes and induced Foxp3+ Treg conversion in IPAH T cells. Rodent models recapitulated these epigenetic aberrations and T-cell dysfunction. SAHA attenuated PH phenotypes and restored FOXP3 transcription and Tregs in PH rats; interestingly, the effects were more profound in female rats. Selective depletion of CD25+ Tregs in Sugen5416-hypoxia mice neutralized the effects of SAHA. Furthermore, SAHA inhibited endothelial cytokine/chemokine release upon stimulation and subsequent immune chemotaxis. Conclusions: Our results indicated HDAC aberration was associated with Foxp3+ Treg deficiency and demonstrated an epigenetic-mediated mechanism underlying immune dysfunction in PAH. Restoration of Foxp3+ Tregs by HDAC inhibitors is a promising approach to resolve pulmonary vascular pathology, highlighting the potential benefit of developing epigenetic therapies for PAH.
引用
- Chen CN, Hajji N, Yeh FC, et al. Restoration of Foxp3+ Regulatory T Cells by HDAC-Dependent Epigenetic Modulation Plays a Pivotal Role in Resolving Pulmonary Arterial Hypertension Pathology. Am J Respir Crit Care Med. 2023. PMID: 37676930. doi:10.1164/rccm.202301-0181OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。